AI Analysis

How does 950210.KS make money? Does 950210.KS have pricing power? What's the Earnings Whisper? Will 950210.KS profit more as the business scales? What is 950210.KS's management track record? Is 950210.KS's current price justified?

Prestige BioPharma Limited

₩6130 -$7430.00 (-54.79%)

KSC · 14 Sep 2026 06:30 UTC

Previous Close

₩6190

Day Range

₩5960₩6260

Year Range

₩4945₩15110

Market Cap

368.39B

AVG Volume

75.89K

Trailing/Forward PE

-3.08/-

PEG ratio

0.04

Dividend Yield

Next Earnings Date

Primary Exchange

Korea Exchange

Revenue (KRW) · TTM

950210.KS Revenue (KRW) · TTM by quarter
Period	Revenue (KRW) · TTM
25 Q4	25.23B
25 Q3	16.22B
25 Q2	19.04B
25 Q1	14.28B
24 Q4	14.19B
24 Q3	8.54B
24 Q2	5.84B
24 Q1	2.84B
23 Q4	688.75M
23 Q3	986.9M

Net Income (KRW) · TTM

950210.KS Net Income (KRW) · TTM by quarter
Period	Net Income (KRW) · TTM
25 Q4	-96.68B
25 Q3	-57.54B
25 Q2	13.96B
25 Q1	16.17B
24 Q4	22.72B
24 Q3	22.21B
24 Q2	-29.69B
24 Q1	-29.48B
23 Q4	-32.82B
23 Q3	-32.34B

Operating Income (KRW) · TTM

950210.KS Operating Income (KRW) · TTM by quarter
Period	Operating Income (KRW) · TTM
25 Q4	-92.74B
25 Q3	-84.58B
25 Q2	-72.97B
25 Q1	-75.86B
24 Q4	-67.1B
24 Q3	-62.57B
24 Q2	-63.96B
24 Q1	-60.93B
23 Q4	-62.6B
23 Q3	-73.75B

EBITDA (KRW) · TTM

950210.KS EBITDA (KRW) · TTM by quarter
Period	EBITDA (KRW) · TTM
25 Q4	-68.95B
25 Q3	-43.94B
25 Q2	-36.91B
25 Q1	-43.21B
24 Q4	-6.11B
24 Q3	-13.81B
24 Q2	-16.37B
24 Q1	-6.26B
23 Q4	-38.41B
23 Q3	17.69B

Cash Flows (KRW) · TTM

950210.KS Cash Flows (KRW) · TTM by quarter
Period	Cash Flows (KRW) · TTM
25 Q3	-59.35B
25 Q2	-68.65B
25 Q1	-78.06B
24 Q4	-94.87B
24 Q3	-101.1B
24 Q2	-94.84B
24 Q1	-90.66B
23 Q4	-76.04B
23 Q3	-89.6B
23 Q2	-97B

EPS (KRW) · TTM

950210.KS EPS (KRW) · TTM by quarter
Period	EPS (KRW) · TTM
25 Q4	-1992.98
25 Q3	-957.25
25 Q2	231.19
25 Q1	264.18
24 Q4	372.92
24 Q3	364.43
24 Q2	-497.9
24 Q1	-490.5
23 Q4	-546.24
23 Q3	-538.28

Expenses (KRW) · TTM

950210.KS Expenses (KRW) · TTM by quarter
Period	Expenses (KRW) · TTM
23 Q2	46.34B
25 Q4	63.26B
25 Q3	44.78B
25 Q2	73.76B
25 Q1	91.18B
24 Q4	84.47B
24 Q3	89.79B
24 Q2	64.1B
24 Q1	57.6B
23 Q4	53.33B
23 Q3	85.92B

Shares Outstanding · TTM

950210.KS Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0
23 Q4	0
23 Q3	0
23 Q2	0

PE Ratio

950210.KS PE Ratio by quarter
Period	PE Ratio
Jun 26	25.45
Jun 26	28.38
Jun 26	29.97
Jun 26	29.24
May 26	29.84
May 26	33.59
May 26	33.5
May 26	34.45
Apr 26	38.37
Apr 26	39.7
Apr 26	42.8
Apr 26	39.36
Apr 26	41.34
Mar 26	38.26
Mar 26	36.03
Mar 26	36.25
Mar 26	37.26
Feb 26	39.64
Feb 26	43.77
Feb 26	44.59
Feb 26	43.36
Jan 26	42.06
Jan 26	42.92
Jan 26	44.78
Jan 26	48.09
Jan 26	50.47
Dec 25	32.67
Dec 25	34.52
Dec 25	34.18
Dec 25	36.16
Nov 25	34.66
Nov 25	31.38
Nov 25	33.28
Nov 25	31.53
Oct 25	32.99
Oct 25	32.8
Oct 25	33.7
Oct 25	34.05
Oct 25	34.44
Sep 25	36.35
Sep 25	39.82
Sep 25	39.79
Sep 25	40.03
Aug 25	37.13
Aug 25	37.59
Aug 25	42.61
Aug 25	39.76
Aug 25	37.97
Jul 25	41.01
Jul 25	43.64
Jul 25	49.95
Jul 25	50.6
Dec 23	31.94
Dec 23	31.53
Dec 23	31.7
Dec 23	32.11
Dec 23	33.22
Nov 23	33.99
Nov 23	33.65
Nov 23	33.49
Nov 23	33.82
Oct 23	33.79
Oct 23	33.76
Oct 23	35.84
Oct 23	34.09

Free Cash Flow Yield

950210.KS Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-15.95%
Sep 26	-15.19%
Aug 26	-15.36%
Aug 26	-16.27%
Aug 26	-13.72%
Aug 26	-14.96%
Jul 26	-15.43%
Jul 26	-18.81%
Jul 26	-18.67%
Jul 26	-17.14%
Jul 26	-16.32%
Jun 26	-19.33%
Jun 26	-17.33%
Jun 26	-16.41%
Jun 26	-16.82%
May 26	-16.48%
May 26	-14.65%
May 26	-14.68%
May 26	-14.28%
Apr 26	-12.82%
Apr 26	-12.39%
Apr 26	-11.49%
Apr 26	-12.5%
Apr 26	-11.9%
Mar 26	-12.62%
Mar 26	-13.4%
Mar 26	-13.32%
Mar 26	-12.96%
Feb 26	-12.18%
Feb 26	-11.03%
Feb 26	-10.83%
Feb 26	-11.14%
Jan 26	-11.48%
Jan 26	-11.25%
Jan 26	-10.78%
Jan 26	-10.04%
Jan 26	-9.57%
Dec 25	-12.78%
Dec 25	-12.1%
Dec 25	-12.22%
Dec 25	-11.55%
Nov 25	-12.05%
Nov 25	-13.31%
Nov 25	-12.55%
Nov 25	-13.24%
Oct 25	-12.66%
Oct 25	-12.73%
Oct 25	-12.39%
Oct 25	-12.27%
Oct 25	-12.13%
Sep 25	-12.53%
Sep 25	-11.43%
Sep 25	-11.44%
Sep 25	-11.37%
Aug 25	-12.26%
Aug 25	-12.11%
Aug 25	-10.68%
Aug 25	-11.45%
Aug 25	-11.99%
Jul 25	-11.1%
Jul 25	-10.43%
Jul 25	-9.11%
Jul 25	-9%
Jun 25	-13.52%
Jun 25	-13.29%
Jun 25	-13.05%
Jun 25	-12.1%
May 25	-12.12%
May 25	-12.2%
May 25	-12.07%
May 25	-11.91%
May 25	-11.36%
Apr 25	-10.5%
Apr 25	-10.84%
Apr 25	-11.03%
Apr 25	-11.75%
Mar 25	-11.33%
Mar 25	-12.79%
Mar 25	-11%
Mar 25	-11.32%
Feb 25	-11.04%
Feb 25	-10.31%
Feb 25	-9.96%
Feb 25	-9.9%
Jan 25	-10.38%
Jan 25	-10%
Jan 25	-9.75%
Jan 25	-9.83%
Jan 25	-9.66%
Dec 24	-8.91%
Dec 24	-8.79%
Dec 24	-8.32%
Dec 24	-8.52%
Nov 24	-8.97%
Nov 24	-8.58%
Nov 24	-7.71%
Nov 24	-7.03%
Nov 24	-7.36%
Oct 24	-7.16%
Oct 24	-8.49%

Price to Sales

950210.KS Price to Sales by quarter
Period	Price to Sales
Sep 26	22.94
Sep 26	24.09
Aug 26	23.83
Aug 26	22.49
Aug 26	26.68
Aug 26	24.46
Jul 26	23.72
Jul 26	19.46
Jul 26	19.6
Jul 26	21.35
Jul 26	22.42
Jun 26	18.66
Jun 26	20.8
Jun 26	21.97
Jun 26	21.44
May 26	21.88
May 26	24.62
May 26	24.56
May 26	25.26
Apr 26	28.13
Apr 26	29.11
Apr 26	31.38
Apr 26	28.85
Apr 26	30.31
Mar 26	43.32
Mar 26	40.8
Mar 26	41.05
Mar 26	42.19
Feb 26	44.88
Feb 26	49.56
Feb 26	50.49
Feb 26	49.1
Jan 26	47.62
Jan 26	48.59
Jan 26	50.7
Jan 26	54.45
Jan 26	57.15
Dec 25	52.3
Dec 25	55.26
Dec 25	54.71
Dec 25	57.89
Nov 25	55.47
Nov 25	50.22
Nov 25	53.27
Nov 25	50.48
Oct 25	52.81
Oct 25	52.51
Oct 25	53.95
Oct 25	54.5
Oct 25	55.14
Sep 25	94.52
Sep 25	103.54
Sep 25	103.47
Sep 25	104.11
Aug 25	96.56
Aug 25	97.76
Aug 25	110.8
Aug 25	103.4
Aug 25	98.75
Jul 25	106.64
Jul 25	113.48
Jul 25	129.9
Jul 25	131.59
Jun 25	120.12
Jun 25	122.24
Jun 25	124.47
Jun 25	134.28
May 25	134.08
May 25	133.17
May 25	134.59
May 25	136.41
May 25	142.98
Apr 25	154.72
Apr 25	149.87
Apr 25	147.23
Apr 25	138.23
Mar 25	281.55
Mar 25	249.42
Mar 25	290.01
Mar 25	281.77
Feb 25	288.95
Feb 25	309.24
Feb 25	320.24
Feb 25	322.14
Jan 25	307.34
Jan 25	318.76
Jan 25	327
Jan 25	324.25
Jan 25	329.96
Dec 24	1239
Dec 24	1256.45
Dec 24	1326.26
Dec 24	1295.72
Nov 24	1231.15
Nov 24	1286.99
Nov 24	1432.71
Nov 24	1570.57
Nov 24	1500.76
Oct 24	1540.9
Oct 24	1300.08

EV/EBITDA

950210.KS EV/EBITDA by quarter
Period	EV/EBITDA
Sep 24	38.73
Sep 24	41.38
Sep 24	37.1
Sep 24	34.69
Aug 24	39.21
Aug 24	37.1
Aug 24	44.78
Aug 24	38.02
Aug 24	34.11
Jul 24	37.98
Jul 24	31.66
Jul 24	23.64
Jul 24	22.46
Jun 24	42.77
Jun 24	44.04
Jun 24	44.4
Jun 24	43.12
May 24	39.2
May 24	37.87
May 24	39.71
May 24	39.55
May 24	39.96
Apr 24	39.45
Apr 24	39.6
Apr 24	40.47
Apr 24	42.71
Mar 24	129.45
Mar 24	129.21
Mar 24	123.11
Mar 24	120.29
Feb 24	122.87
Feb 24	122.87
Feb 24	119.12
Feb 24	110.9
Feb 24	112.54
Jan 24	112.31
Jan 24	127.1
Jan 24	140.95
Jan 24	144.7
Dec 23	5.1
Dec 23	5
Dec 23	5.04
Dec 23	5.14
Dec 23	5.43
Nov 23	5.63
Nov 23	5.54
Nov 23	5.5
Nov 23	5.59
Oct 23	5.58
Oct 23	5.57
Oct 23	6.11
Oct 23	5.66

Price to Book

950210.KS Price to Book by quarter
Period	Price to Book
Sep 26	0.66
Sep 26	0.7
Aug 26	0.69
Aug 26	0.65
Aug 26	0.77
Aug 26	0.71
Jul 26	0.69
Jul 26	0.56
Jul 26	0.57
Jul 26	0.62
Jul 26	0.65
Jun 26	0.73
Jun 26	0.82
Jun 26	0.86
Jun 26	0.84
May 26	0.86
May 26	0.97
May 26	0.97
May 26	0.99
Apr 26	1.11
Apr 26	1.14
Apr 26	1.23
Apr 26	1.13
Apr 26	1.19
Mar 26	1.24
Mar 26	1.17
Mar 26	1.17
Mar 26	1.21
Feb 26	1.28
Feb 26	1.42
Feb 26	1.44
Feb 26	1.4
Jan 26	1.36
Jan 26	1.39
Jan 26	1.45
Jan 26	1.56
Jan 26	1.63
Dec 25	1.47
Dec 25	1.55
Dec 25	1.54
Dec 25	1.62
Nov 25	1.56
Nov 25	1.41
Nov 25	1.49
Nov 25	1.42
Oct 25	1.48
Oct 25	1.47
Oct 25	1.51
Oct 25	1.53
Oct 25	1.55
Sep 25	1.49
Sep 25	1.63
Sep 25	1.63
Sep 25	1.64
Aug 25	1.52
Aug 25	1.54
Aug 25	1.75
Aug 25	1.63
Aug 25	1.56
Jul 25	1.68
Jul 25	1.79
Jul 25	2.05
Jul 25	2.08
Jun 25	1.42
Jun 25	1.45
Jun 25	1.47
Jun 25	1.59
May 25	1.59
May 25	1.58
May 25	1.59
May 25	1.61
May 25	1.69
Apr 25	1.83
Apr 25	1.77
Apr 25	1.74
Apr 25	1.64
Mar 25	1.64
Mar 25	1.45
Mar 25	1.69
Mar 25	1.64
Feb 25	1.68
Feb 25	1.8
Feb 25	1.86
Feb 25	1.87
Jan 25	1.79
Jan 25	1.85
Jan 25	1.9
Jan 25	1.89
Jan 25	1.92
Dec 24	1.66
Dec 24	1.68
Dec 24	1.77
Dec 24	1.73
Nov 24	1.64
Nov 24	1.72
Nov 24	1.91
Nov 24	2.1
Nov 24	2.01
Oct 24	2.06
Oct 24	1.74

No video analysis for this stock yet. Request one from our team.

AI Analysis

Prestige BioPharma Limited

Video analysis: 950210.KS

Similar companies